Exploring fetal brain tumor glioblastoma symptom verification with self organizing maps and vulnerability data analysis.

Brain tumor glioblastoma is a disease that is caused for a child who has abnormal cells in the brain, which is found using MRI "Magnetic Resonance Imaging" brain image using a powerful magnetic field, radio waves, and a computer to produce detailed images of the body's internal structures it is a standard diagnostic tool for a wide range of medical conditions, from detecting brain and spinal cord injuries to identifying tumors and also in evaluating joint problems. This is treatable, and by enabling the factor for happening, the factor for dissolving the dead tissues. If the brain tumor glioblastoma is untreated, the child will go to death; to avoid this, the child has to treat the brain problem using the scan of MRI images. Using the neural network, brain-related difficulties have to be resolved. It is identified to make the diagnosis of glioblastoma. This research deals with the techniques of max rationalizing and min rationalizing images, and the method of boosted division time attribute extraction has been involved in diagnosing glioblastoma. The process of maximum and min rationalization is used to recognize the Brain tumor glioblastoma in the brain images for treatment efficiency. The image segment is created for image recognition. The method of boosted division time attribute extraction is used in image recognition with the help of MRI for image extraction. The proposed boosted division time attribute extraction method helps to recognize the fetal images and find Brain tumor glioblastoma with feasible accuracy using image rationalization against the brain tumor glioblastoma diagnosis. In addition, 45% of adults are affected by the tumor, 40% of children and 5% are in death situations. To reduce this ratio, in this study, the Brain tumor glioblastoma is identified and segmented to recognize the fetal images and find the Brain tumor glioblastoma diagnosis. Then the tumor grades were analyzed using the efficient method for the imaging MRI with the diagnosis result of partially high. The accuracy of the proposed TAE-PIS system is 98.12% which is higher when compared to other methods like Genetic algorithm, Convolution neural network, fuzzy-based minimum and maximum neural network and kernel-based support vector machine respectively. Experimental results show that the proposed method archives rate of 98.12% accuracy with low response time and compared with the Genetic algorithm (GA), Convolutional Neural Network (CNN), fuzzy-based minimum and maximum neural network (Fuzzy min-max NN), and kernel-based support vector machine. Specifically, the proposed method achieves a substantial improvement of 80.82%, 82.13%, 85.61%, and 87.03% compared to GA, CNN, Fuzzy min-max NN, and kernel-based support vector machine, respectively.

An active learning machine technique based prediction of cardiovascular heart disease from UCI-repository database.

Heart disease is a significant global cause of mortality, and predicting it through clinical data analysis poses challenges. Machine learning (ML) has emerged as a valuable tool for diagnosing and predicting heart disease by analyzing healthcare data. Previous studies have extensively employed ML techniques in medical research for heart disease prediction. In this study, eight ML classifiers were utilized to identify crucial features that enhance the accuracy of heart disease prediction. Various combinations of features and well-known classification algorithms were employed to develop the prediction model. Neural network models, such as Naïve Bayes and Radial Basis Functions, were implemented, achieving accuracies of 94.78% and 90.78% respectively in heart disease prediction. Among the state-of-the-art methods for cardiovascular problem prediction, Learning Vector Quantization exhibited the highest accuracy rate of 98.7%. The motivation behind predicting Cardiovascular Heart Disease lies in its potential to save lives, improves health outcomes, and allocates healthcare resources efficiently. The key contributions encompass early intervention, personalized medicine, technological advancements, the impact on public health, and ongoing research, all of which collectively work toward reducing the burden of CHD on both individual patients and society as a whole.